Global, regional, and national burden and quality of care index of liver cirrhosis by cause from global burden of disease 1990–2019
暂无分享,去创建一个
F. Farzadfar | B. Larijani | E. Ghasemi | S. Saeedi Moghaddam | N. Rezaei | Parnian Shobeiri | M. Abbasi-Kangevari | N. Fattahi | Esmaeil Mohammadi | S. Azadnajafabad | Fateme Gorgani | Zahra Esfahani | Yosef Farzi | Seyyed-Hadi Ghamari | Yeganeh Sharifnejad Tehrani | Sina Azadnajafabad | S. Ghamari | Sahar Saeedi Moghaddam
[1] F. Farzadfar,et al. Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 , 2022, Hepatology communications.
[2] Yasuhito Tanaka,et al. Seamless support from screening to anti-HCV treatment and HCC/ decompensated cirrhosis: Subsidy programs for HCV elimination. , 2021, Global health & medicine.
[3] F. Farzadfar,et al. Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990-2017. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[4] Z. Younossi,et al. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. , 2021, Journal of hepatology.
[5] F. Farzadfar,et al. Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2021, European journal of preventive cardiology.
[6] H. Gharib,et al. Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 , 2021, Cancer medicine.
[7] F. Farzadfar,et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017 , 2021, PloS one.
[8] F. Farzadfar,et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 , 2021, Experimental Hematology & Oncology.
[9] U. Strömberg,et al. Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden , 2020, BMC Public Health.
[10] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[11] Dan J Stein,et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[12] S. Saab,et al. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults , 2020, JAMA network open.
[13] T. H. Nguyen,et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.
[14] M. Kurosaki,et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey , 2019, Journal of Gastroenterology.
[15] M. Esmaeili,et al. Quality of Life in Patients With Liver Cirrhosis: A Systematic Review , 2019, Hospital Practices and Research.
[16] M. Coleman,et al. The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival , 2019, Journal of global oncology.
[17] S. Terai,et al. Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients , 2019, World journal of gastroenterology.
[18] P. Kamath,et al. Burden of liver diseases in the world. , 2019, Journal of hepatology.
[19] Wei Jia,et al. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation , 2018, Hepatoma research.
[20] S. Mohanty,et al. Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients , 2018, Gastroenterology research.
[21] W. Sung,et al. Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries , 2018, BMJ Open.
[22] L. Boudarène,et al. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries , 2018, BMC Public Health.
[23] M. Saberifiroozi. Improving Quality of Care in Patients with Liver Cirrhosis , 2017, Middle East journal of digestive diseases.
[24] M. Kruk,et al. Measuring quality of health-care services: what is known and where are the gaps? , 2017, Bulletin of the World Health Organization.
[25] T. Kanto,et al. Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.
[26] P. Pontisso,et al. Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report , 2017, Digestive Diseases.
[27] Chih-jen Wu,et al. Influence of Age on Critically Ill Patients with Cirrhosis , 2015 .
[28] Stephen A. Martin,et al. Care that Matters: Quality Measurement and Health Care , 2015, PLoS medicine.
[29] Y. Osaki,et al. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis , 2015, Mediators of inflammation.
[30] A. Allen,et al. Review article: the management of cirrhosis in women , 2014, Alimentary pharmacology & therapeutics.
[31] Mohsen Naghavi,et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.
[32] A. Mosadeghrad,et al. Healthcare Service Quality: Towards a Broad Definition , 2013, International journal of health care quality assurance.
[33] M. Peters,et al. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. , 2013, Gastroenterology & hepatology.
[34] N. Kemmer,et al. Update on the management of cirrhosis – focus on cost-effective preventative strategies , 2013, ClinicoEconomics and outcomes research : CEOR.
[35] M. Blachier,et al. Report Title: The burden of liver disease in Europe: a review of available epidemiological data , 2013 .
[36] Eliot J Lazar,et al. Quality measurement in healthcare. , 2013, Annual review of medicine.
[37] F. Cainelli. Liver diseases in developing countries. , 2012, World journal of hepatology.
[38] E. Schiff,et al. The current economic burden of cirrhosis. , 2011, Gastroenterology & hepatology.
[39] H. Sørensen,et al. Socioeconomic status and survival of cirrhosis patients: A Danish nationwide cohort study , 2009, BMC gastroenterology.
[40] Alvin C. Rencher,et al. A Review Of “Methods of Multivariate Analysis, Second Edition” , 2005 .
[41] G. Becker,et al. Socioeconomic status and dissatisfaction with health care among chronically ill African Americans. , 2003, American journal of public health.
[42] R H Brook,et al. Can health care quality indicators be transferred between countries? , 2003, Quality & safety in health care.
[43] E. Smith. Methods of Multivariate Analysis , 1997 .
[44] M. Kew,et al. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. , 1996, Gut.
[45] A. B. Sukhomlinov,et al. [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.